Publications

Detailed Information

Prevalence and Its Predictors of Extrapulmonary Involvement in Patients with Pulmonary Tuberculosis

DC Field Value Language
dc.contributor.authorKim, Min Jae-
dc.contributor.authorKim, Hye-Ryoun-
dc.contributor.authorHwang, Seung Sik-
dc.contributor.authorKim, Young Whan-
dc.contributor.authorShim, Young-Soo-
dc.contributor.authorYim, Jae-Joon-
dc.contributor.authorHan, Sung Koo-
dc.date.accessioned2012-05-23T06:50:27Z-
dc.date.available2012-05-23T06:50:27Z-
dc.date.issued2009-04-
dc.identifier.citationJOURNAL OF KOREAN MEDICAL SCIENCE; Vol.24 2; 237-241ko_KR
dc.identifier.issn1011-8934-
dc.identifier.urihttps://hdl.handle.net/10371/76332-
dc.description.abstractExtrapulmonary organ involvement in human immunodefiaency virus (HIV)-infected patients with pulmonary tuberculosis (TB) is reported to be 26%, however, the clinical predictors of extrapulmonary involvement in pulmonary TB patients has not been reported yet. We tried to determine the clinical predictors of presence of extrapulmonary involvement in patients with pulmonary TB. Cross-sectional study was performed including all adult patients with culture-proven pulmonary TB diagnosed between January 1, 2004 and July 30, 2006, at a tertiary referral hospital in South Korea. The presence of extra-pulmonary TB involvement was diagnosed based on bacteriological, pathological, or clinical evidence. Among 320 patients with a culture-proven pulmonary TB, 40 had extrapulmonary involvement. Patients with bilateral lung involvement were more likely to have extrapulmonary involvement, with an adjusted odds ratio (OR) of 4.21 (95% confidence interval [CI], 1.82-9.72), while patients older than 60 yr (adjusted OR, 0.27; 95% CI, 0.08-0.89), patients with cavitary lesions (adjusted OR, 0.37; 95% CI, 0.16-0.84), and with higher levels of serum albumin (adjusted OR, 0.45; 95% CI, 0.25-0.78) had less frequent involvement. Clinicians should be aware of the possibility of extrapulmonary involvement in TB patients with bilateral lung involvement without cavity formation or lower levels of serum albumin.ko_KR
dc.language.isoenko_KR
dc.publisherKOREAN ACAD MEDICAL SCIENCESko_KR
dc.subjectTuberculosisko_KR
dc.subjectTuberculosis, Miliaryko_KR
dc.subjectDiagnosisko_KR
dc.titlePrevalence and Its Predictors of Extrapulmonary Involvement in Patients with Pulmonary Tuberculosisko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김민재-
dc.contributor.AlternativeAuthor김혜련-
dc.contributor.AlternativeAuthor황승식-
dc.contributor.AlternativeAuthor김영환-
dc.contributor.AlternativeAuthor한성구-
dc.contributor.AlternativeAuthor심영수-
dc.contributor.AlternativeAuthor임재준-
dc.identifier.doi10.3346/jkms.2009.24.2.237-
dc.citation.journaltitleJOURNAL OF KOREAN MEDICAL SCIENCE-
dc.description.citedreferenceKim DK, 2006, RESPIROLOGY, V11, P557, DOI 10.1111/j.1400-1843.2006.00896.x-
dc.description.citedreferenceErgun I, 2006, TRANSPLANT P, V38, P1344, DOI 10.1016/j.transproceed.2006.03.029-
dc.description.citedreferenceKim HJ, 2006, CHEST, V129, P1253-
dc.description.citedreferenceBABELA JRM, 2006, MED TROP-MARSEILLE, V66, P255-
dc.description.citedreferenceCailhol J, 2005, J CLIN EPIDEMIOL, V58, P1066, DOI 10.1016/j.jclinepi.2005.02.023-
dc.description.citedreferenceDrobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726-
dc.description.citedreferenceVesosky B, 2005, IMMUNOL REV, V205, P229-
dc.description.citedreferenceAderaye G, 2004, INFECTION, V32, P333, DOI 10.1007/s15010-004-3089-x-
dc.description.citedreferenceCrump JA, 2003, CLIN INFECT DIS, V37, P1037-
dc.description.citedreferenceLopez B, 2003, CLIN EXP IMMUNOL, V133, P30-
dc.description.citedreferenceKim JY, 2003, INT J TUBERC LUNG D, V7, P359-
dc.description.citedreferenceHussein MM, 2003, SEMIN DIALYSIS, V16, P38-
dc.description.citedreferenceBenator D, 2002, LANCET, V360, P528-
dc.description.citedreferenceMERT A, 2001, RESPIROLOGY, V6, P217-
dc.description.citedreferenceKaryadi E, 2000, J NUTR, V130, P2953-
dc.description.citedreferenceHUANG J, 2000, ZHONGHUA JIE HE HE H, V23, P606-
dc.description.citedreferenceLADO FLL, 1999, SCAND J INFECT DIS, V31, P389-
dc.description.citedreferenceDai GX, 1998, INFECT IMMUN, V66, P3562-
dc.description.citedreferenceMainali ES, 1998, INFECT IMMUN, V66, P927-
dc.description.citedreferenceHong YP, 1998, INT J TUBERC LUNG D, V2, P27-
dc.description.citedreferenceCowie RL, 1997, INT J TUBERC LUNG D, V1, P159-
dc.description.citedreferenceKEIPER MD, 1995, CHEST, V107, P74-
dc.description.citedreferenceMOUDGIL H, 1994, RESP MED, V88, P301-
dc.description.citedreferenceKENT SJ, 1993, CLIN INFECT DIS, V17, P987-
dc.description.citedreferenceJONES BE, 1993, AM REV RESPIR DIS, V148, P1292-
dc.description.citedreferenceBATUNGWANAYO J, 1992, AM REV RESPIR DIS, V146, P53-
dc.description.citedreferenceSTEAD WW, 1991, ANNU REV MED, V42, P267-
dc.description.citedreferenceANTONISKIS D, 1990, AM J MED, V89, P447-
dc.description.citedreferenceMAARTENS G, 1990, AM J MED, V89, P291-
dc.description.citedreferenceKIM JH, 1990, REV INFECT DIS, V12, P583-
dc.description.citedreferenceRIEDER HL, 1990, AM REV RESPIR DIS, V141, P347-
dc.description.citedreferenceRAMACHANDRAN P, 1989, TUBERCLE, V70, P235-
dc.description.citedreferenceONWUBALILI JK, 1988, EUR J CLIN NUTR, V42, P363-
dc.description.tc2-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share